Nexxen insider plans sale of 70,000 shares

Sagi Niri filed to sell up to 70,000 ordinary shares of Nexxen International Ltd. through Oppenheimer & Co. Inc., with a proposed aggregate sale price of $675,500.00 on Nasdaq.

Rhea-AI Filing Summary

Sagi Niri filed to sell up to 70,000 ordinary shares of Nexxen International Ltd. through Oppenheimer & Co. Inc., with a proposed aggregate sale price of $675,500.00 on Nasdaq. The shares include stock issued upon vesting of RSUs on June 30, 2025 and March 31, 2026, for which no cash consideration was paid. The filing also lists multiple ordinary-share sales in the past three months, including 68,886 shares sold on June 29, 2026 for $625,582.37.

Filing Explained

The July 13 notice concerns a proposed 70,000-share insider sale; it describes possible holder-level selling, not completed issuance, dilution, or company proceeds.

The July 13, 2026 Form 144 identifies Sagi Niri as proposing to sell 70,000 Nexxen ordinary shares through Oppenheimer & Co.; it is a sale notice, not evidence that those shares have been sold, and it does not itself change Nexxen's issued shares or establish proceeds for the company.

The shares listed for sale are attributed to RSUs that vested on June 30, 2025 and March 31, 2026, with no consideration shown for their issuance; the filing separately reports that the filer held 56,284,083 ordinary shares before the proposed sale.

The filing also records the filer's prior ordinary-share sales from May 29, 2026 through July 10, 2026, including the most recent sale of 3,655 shares on July 10, 2026.

The specific item to monitor is whether the 70,000-share sale identified in the July 13 notice is later reported as completed; the filing does not disclose a trading plan.

Key Figures

Planned shares to be sold: 70,000 shares Proposed aggregate sale price: $675,500.00 RSU vesting issuance 1: 121,951 shares +4 more

7 metrics

Planned shares to be sold 70,000 shares Ordinary shares to be sold through Oppenheimer & Co. Inc. on Nasdaq

Proposed aggregate sale price $675,500.00 Aggregate price for 70,000 ordinary shares in the planned sale

RSU vesting issuance 1 121,951 shares Ordinary shares issued upon vesting of RSUs on June 30, 2025

RSU vesting issuance 2 17,421 shares Ordinary shares issued upon vesting of RSUs on June 30, 2025

RSU vesting issuance 3 75,386 shares Ordinary shares issued upon vesting of RSUs on March 31, 2026

Sale on June 29, 2026 68,886 shares for $625,582.37 Ordinary shares sold by Sagi Niri during the past three months

Sale on July 2, 2026 49,826 shares for $475,574.20 Ordinary shares sold by Sagi Niri during the past three months

Key Terms

Form 144, RSUs, No consideration

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSUs financial

"Shares issued upon vesting of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

No consideration financial

"No consideration, shares issued upon vesting of RSUs"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Nexxen International (NEXN) insider Sagi Niri plan to sell under this filing?

Sagi Niri plans to sell up to 70,000 ordinary shares of Nexxen International Ltd. through Oppenheimer & Co. Inc., with a proposed aggregate sale price of $675,500.00 on Nasdaq.

How were the Nexxen International (NEXN) shares obtained that are referenced in this filing?

The filing notes shares were issued upon vesting of RSUs on June 30, 2025 and March 31, 2026. The description states there was “No consideration, shares issued upon vesting of RSUs.”

Which broker is handling the planned Nexxen (NEXN) share sale for Sagi Niri?

The planned sale of up to 70,000 ordinary shares of Nexxen International Ltd. is listed with Oppenheimer & Co. Inc. at 85 Broad St., New York, as the broker, for trading on Nasdaq.

What recent Nexxen (NEXN) share sales by Sagi Niri are disclosed in the past three months?

The filing lists multiple recent sales of ordinary shares, including 68,886 shares on June 29, 2026 for $625,582.37 and 49,826 shares on July 2, 2026 for $475,574.20, among other smaller trades.

On which market are the Nexxen International (NEXN) shares intended to be sold?

The ordinary shares covered by this planned sale of up to 70,000 shares of Nexxen International Ltd., with a proposed value of $675,500.00, are listed to be sold on the Nasdaq market.

Does this Nexxen (NEXN) filing involve cash paid for the RSU-related shares?

No cash was paid for the RSU-related shares. The disclosure explicitly states “No consideration, shares issued upon vesting of RSUs” for issuances on June 30, 2025 and March 31, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001980194
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Nexxen International Ltd.
SEC File Number	001-40504
Address of Issuer	82 YIGAL ALON STREET 13TH FLOOR TEL AVIV ISRAEL 6789124
Phone	972-3-545-3900
Name of Person for Whose Account the Securities are To Be Sold	Niri Sagi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	70000	675500.00	56284083	07/13/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	06/30/2025	Shares issued upon vesting of RSUs	Nexxen International Ltd.			121951	06/30/2025	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	06/30/2025	Shares issued upon vesting of RSUs	Nexxen International Ltd.			17421	06/30/2025	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	03/31/2026	Shares issued upon vesting of RSUs	Nexxen International Ltd.			75386	03/31/2026	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sagi Niri 82 YIGAL ALON STREET TEL AVIV L3 00000	Ordinary Shares	05/29/2026	1486	12635.90
Sagi Niri 82 YIGAL ALON STREET TEL AVIV L3 00000	Ordinary Shares	06/01/2026	33757	291289.73
Sagi Niri 82 YIGAL ALON STREET TEL AVIV L3 00000	Ordinary Shares	06/02/2026	18660	159055.97
Sagi Niri 82 YIGAL ALON STREET TEL AVIV L3 00000	Ordinary Shares	06/03/2026	1100	9438.00
Sagi Niri 82 YIGAL ALON STREET TEL AVIV L3 00000	Ordinary Shares	06/04/2026	13164	112376.00
Sagi Niri 82 YIGAL ALON STREET TEL AVIV L3 00000	Ordinary Shares	06/10/2026	5922	51755.32
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	06/12/2026	200	1740.00
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	06/15/2026	1160	10100.12
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	06/16/2026	34667	304459.77
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	06/17/2026	2098	18412.68
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	06/29/2026	68886	625582.37
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	07/01/2026	42692	399739.24
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	07/02/2026	49826	475574.20
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	07/06/2026	199	1898.46
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 00000	Ordinary Shares	07/10/2026	3655	35580.33

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b51 trading plan adopted on 08/19/2025
Date of Notice	07/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Sagi Niri By: /s/ Yohanan Azriel Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)